The immunosurveillance signature predicts the prognosis and immunotherapy sensitivity for colon adenocarcinoma

ABSTRACT:

SUBMITTER: Xiong Y 

PROVIDER: S-EPMC12144195 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature